This is the cold season, and many people are down with runny nose, fever, cough, and tiredness. However, according to experts ...

The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

Members of the Leukemia and Lymphoma Society discussed the importance of educating others, fundraising and spreading ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

points to a trend toward more integrated and comprehensive imaging approaches in lymphoma diagnosis (45). This study has several potential limitations. First, relying on citation counts may not fully ...

Leukemia and lymphoma can have similar symptoms, including fevers, fatigue, and frequent infections. However, they do also have symptoms that make them distinct from each other. Leukemia and lymphoma ...

A panelist discusses how patients should communicate comprehensively with their care team about symptom patterns, documentation methods, and warning signs of polycythemia vera progression, including ...

Actress Susan Sullivan, 82, who announced she was “cancer-free” from non-small cell lung cancer (the most common type of lung cancer) last year, is now battling lymphoma ... at the 2024 American ...

Currently, most treatments for cutaneous T-cell lymphoma do not produce long-lasting benefits, said Timothy Kuzel, MD, '87 '90 GME, clinical professor of Medicine in the Division of Hematology and ...

AstraZeneca has received approval from the US Food and Drug Administration (FDA) for its Bruton’s tyrosine kinase (BTK) inhibitor, Calquence (acalabrutinib), for first-line use in mantle cell lymphoma ...